TY - JOUR AU - Rivers, E. AU - Nguyen, B. AU - Havstad, S. PY - 2001 DA - 2001// TI - Early goal-directed therapy in the treatment of severe sepsis and septic shock JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa010307 DO - 10.1056/NEJMoa010307 ID - Rivers2001 ER - TY - JOUR AU - Kumar, A. AU - Roberts, D. AU - Wood, K. E. PY - 2006 DA - 2006// TI - Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock JO - Crit Care Med VL - 34 UR - https://doi.org/10.1097/01.CCM.0000217961.75225.E9 DO - 10.1097/01.CCM.0000217961.75225.E9 ID - Kumar2006 ER - TY - JOUR AU - Vincent, J. L. AU - Bernard, G. R. AU - Beale, R. PY - 2005 DA - 2005// TI - Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment JO - Crit Care Med VL - 33 UR - https://doi.org/10.1097/01.CCM.0000181729.46010.83 DO - 10.1097/01.CCM.0000181729.46010.83 ID - Vincent2005 ER - TY - JOUR AU - Valles, J. AU - Rello, J. AU - Ochagavia, A. AU - Garnacho, J. AU - Alcala, M. A. PY - 2003 DA - 2003// TI - Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival JO - Chest VL - 123 UR - https://doi.org/10.1378/chest.123.5.1615 DO - 10.1378/chest.123.5.1615 ID - Valles2003 ER - TY - CHAP AU - Kresken, M. AU - Hafner, D. AU - Schmitz, F. -. J. AU - Wichelhaus, T. A. AU - Studiengruppe, F. D. PY - 2009 DA - 2009// TI - Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum BT - Antiinfectives Intelligence Rheinbach ID - Kresken2009 ER - TY - JOUR AU - Steinstraesser, L. AU - Kraneburg, U. M. AU - Hirsch, T. PY - 2009 DA - 2009// TI - Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? JO - Int J Mol Sci VL - 10 UR - https://doi.org/10.3390/ijms10093951 DO - 10.3390/ijms10093951 ID - Steinstraesser2009 ER - TY - JOUR AU - Gordon, Y. J. AU - Romanowski, E. G. AU - McDermott, A. M. PY - 2005 DA - 2005// TI - A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs JO - Curr Eye Res VL - 30 UR - https://doi.org/10.1080/02713680590968637 DO - 10.1080/02713680590968637 ID - Gordon2005 ER - TY - JOUR AU - Skarnes, R. C. AU - Watson, D. W. PY - 1957 DA - 1957// TI - Antimicrobial factors of normal tissues and fluids JO - Bacteriol Rev VL - 21 ID - Skarnes1957 ER - TY - JOUR AU - Shafer, W. M. AU - Qu, X. AU - Waring, A. J. AU - Lehrer, R. I. PY - 1998 DA - 1998// TI - Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family JO - Proc Natl Acad Sci USA VL - 95 UR - https://doi.org/10.1073/pnas.95.4.1829 DO - 10.1073/pnas.95.4.1829 ID - Shafer1998 ER - TY - JOUR AU - Yount, N. Y. AU - Bayer, A. S. AU - Xiong, Y. Q. AU - Yeaman, M. R. PY - 2006 DA - 2006// TI - Advances in antimicrobial peptide immunobiology JO - Biopolymers VL - 84 UR - https://doi.org/10.1002/bip.20543 DO - 10.1002/bip.20543 ID - Yount2006 ER - TY - JOUR AU - Peschel, A. PY - 2002 DA - 2002// TI - How do bacteria resist human antimicrobial peptides? JO - Trends Microbiol VL - 10 UR - https://doi.org/10.1016/S0966-842X(02)02333-8 DO - 10.1016/S0966-842X(02)02333-8 ID - Peschel2002 ER - TY - JOUR AU - Hancock, R. E. AU - Sahl, H. G. PY - 2006 DA - 2006// TI - Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies JO - Nat Biotechnol VL - 24 UR - https://doi.org/10.1038/nbt1267 DO - 10.1038/nbt1267 ID - Hancock2006 ER - TY - JOUR AU - Semple, F. AU - Webb, S. AU - Li, H. N. PY - 2010 DA - 2010// TI - Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo JO - Eur J Immunol VL - 40 UR - https://doi.org/10.1002/eji.200940041 DO - 10.1002/eji.200940041 ID - Semple2010 ER - TY - JOUR AU - Rieg, S. AU - Steffen, H. AU - Seeber, S. PY - 2005 DA - 2005// TI - Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo JO - J Immunol VL - 174 UR - https://doi.org/10.4049/jimmunol.174.12.8003 DO - 10.4049/jimmunol.174.12.8003 ID - Rieg2005 ER - TY - JOUR AU - Meyer, J. E. AU - Harder, J. AU - Gorogh, T. PY - 2004 DA - 2004// TI - Human beta-defensin-2 in oral cancer with opportunistic Candida infection JO - Anticancer Res VL - 24 ID - Meyer2004 ER - TY - JOUR AU - Milner, S. M. AU - Ortega, M. R. PY - 1999 DA - 1999// TI - Reduced antimicrobial peptide expression in human burn wounds JO - Burns VL - 25 UR - https://doi.org/10.1016/S0305-4179(98)00192-2 DO - 10.1016/S0305-4179(98)00192-2 ID - Milner1999 ER - TY - JOUR AU - Tao, R. AU - Jurevic, R. J. AU - Coulton, K. K. PY - 2005 DA - 2005// TI - Salivary antimicrobial peptide expression and dental caries experience in children JO - Antimicrob Agents Chemother VL - 49 UR - https://doi.org/10.1128/AAC.49.9.3883-3888.2005 DO - 10.1128/AAC.49.9.3883-3888.2005 ID - Tao2005 ER - TY - STD TI - Lippross S, Klueter T, Steubesand N, et al.: Multiple trauma induces serum production of host defence peptides.Injury, in press. ID - ref18 ER - TY - JOUR AU - Gryllos, I. AU - Tran-Winkler, H. J. AU - Cheng, M. F. PY - 2008 DA - 2008// TI - Induction of group A Streptococcus virulence by a human antimicrobial peptide JO - Proc Natl Acad Sci USA VL - 105 UR - https://doi.org/10.1073/pnas.0803815105 DO - 10.1073/pnas.0803815105 ID - Gryllos2008 ER - TY - JOUR AU - Berkestedt, I. AU - Nelson, A. AU - Bodelsson, M. PY - 2008 DA - 2008// TI - Endogenous antimicrobial peptide LL-37 induces human vasodilatation JO - Br J Anaesth VL - 100 UR - https://doi.org/10.1093/bja/aen074 DO - 10.1093/bja/aen074 ID - Berkestedt2008 ER - TY - JOUR AU - Fukumoto, K. AU - Nagaoka, I. AU - Yamataka, A. PY - 2005 DA - 2005// TI - Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats JO - Pediatr Surg Int VL - 21 UR - https://doi.org/10.1007/s00383-004-1256-x DO - 10.1007/s00383-004-1256-x ID - Fukumoto2005 ER - TY - JOUR AU - Torossian, A. AU - Gurschi, E. AU - Bals, R. AU - Vassiliou, T. AU - Wulf, H. F. AU - Bauhofer, A. PY - 2007 DA - 2007// TI - Effects of the antimicrobial peptide LL-37 and hyperthermic preconditioning in septic rats JO - Anesthesiology VL - 107 UR - https://doi.org/10.1097/01.anes.0000278906.86815.eb DO - 10.1097/01.anes.0000278906.86815.eb ID - Torossian2007 ER - TY - JOUR AU - Zhang, L. AU - Falla, T. J. PY - 2006 DA - 2006// TI - Antimicrobial peptides: therapeutic potential JO - Expert Opin Pharmacother VL - 7 UR - https://doi.org/10.1517/14656566.7.6.653 DO - 10.1517/14656566.7.6.653 ID - Zhang2006 ER - TY - JOUR AU - Giles, F. J. AU - Rodriguez, R. AU - Weisdorf, D. PY - 2004 DA - 2004// TI - A phase III, randomized, doubleblind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy JO - Leuk Res VL - 28 UR - https://doi.org/10.1016/j.leukres.2003.10.021 DO - 10.1016/j.leukres.2003.10.021 ID - Giles2004 ER - TY - JOUR AU - Vallespi, M. G. AU - Glaria, L. A. AU - Reyes, O. AU - Garay, H. E. AU - Ferrero, J. AU - Arana, M. J. PY - 2000 DA - 2000// TI - A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases JO - Clin Diagn Lab Immunol VL - 7 ID - Vallespi2000 ER - TY - JOUR AU - Ried, C. AU - Wahl, C. AU - Miethke, T. PY - 1996 DA - 1996// TI - High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor JO - J Biol Chem VL - 271 UR - https://doi.org/10.1074/jbc.271.45.28120 DO - 10.1074/jbc.271.45.28120 ID - Ried1996 ER - TY - JOUR AU - Andrä, J. AU - Lamata, M. AU - Martinez de Tejada, G. AU - Bartels, R. AU - Koch, M. H. AU - Brandenburg, K. PY - 2004 DA - 2004// TI - Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide JO - Biochem Pharmacol VL - 68 UR - https://doi.org/10.1016/j.bcp.2004.05.054 DO - 10.1016/j.bcp.2004.05.054 ID - Andrä2004 ER - TY - JOUR AU - Andrä, J. AU - Garidel, P. AU - Majerle, A. PY - 2004 DA - 2004// TI - Biophysical characterization of the interaction of Limulus polyphemus endotoxin neutralizing protein with lipopolysaccharide JO - Eur J Biochem VL - 271 UR - https://doi.org/10.1111/j.1432-1033.2004.04134.x DO - 10.1111/j.1432-1033.2004.04134.x ID - Andrä2004 ER - TY - JOUR AU - Andrä, J. AU - Howe, J. AU - Garidel, P. PY - 2007 DA - 2007// TI - Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis JO - Biochem J VL - 406 UR - https://doi.org/10.1042/BJ20070279 DO - 10.1042/BJ20070279 ID - Andrä2007 ER - TY - JOUR AU - Brandenburg, K. AU - Schromm, A. B. AU - Gutsmann, T. PY - 2010 DA - 2010// TI - Endotoxins: Structure, function, and recognition: Relationship between structure, function, and activity JO - Subcell Biochem VL - 53 UR - https://doi.org/10.1007/978-90-481-9078-2_3 DO - 10.1007/978-90-481-9078-2_3 ID - Brandenburg2010 ER - TY - JOUR AU - Pan, C. Y. AU - Chao, T. T. AU - Chen, J. C. PY - 2007 DA - 2007// TI - Shrimp (Penaeus monodon) antilipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice JO - Int Immunopharmacol VL - 7 UR - https://doi.org/10.1016/j.intimp.2007.01.006 DO - 10.1016/j.intimp.2007.01.006 ID - Pan2007 ER - TY - JOUR AU - Kowalski, I. AU - Kaconis, Y. AU - Andrä, J. PY - 2010 DA - 2010// TI - Physicochemical and biological characterization of anti-endotoxin peptides and their influence on lipid properties JO - Protein Pept Lett VL - 17 UR - https://doi.org/10.2174/0929866511009011328 DO - 10.2174/0929866511009011328 ID - Kowalski2010 ER - TY - JOUR AU - Gutsmann, T. AU - Razquin-Olazaran, I. AU - Kowalski, I. PY - 2010 DA - 2010// TI - New antiseptic peptides to protect against endotoxin-mediated shock JO - Antimicrob Agents Chemother VL - 54 UR - https://doi.org/10.1128/AAC.00534-10 DO - 10.1128/AAC.00534-10 ID - Gutsmann2010 ER - TY - JOUR AU - Kaconis, Y. AU - Kowalski, I. AU - Howe, J. PY - 2011 DA - 2011// TI - Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides JO - Biophys J VL - 100 UR - https://doi.org/10.1016/j.bpj.2011.04.041 DO - 10.1016/j.bpj.2011.04.041 ID - Kaconis2011 ER - TY - JOUR AU - Brandenburg, K. AU - Andrä, J. AU - Garidel, P. AU - Gutsmann, T. PY - 2011 DA - 2011// TI - Peptide-based treatment of sepsis JO - Appl Microbiol Biotechnol VL - 90 UR - https://doi.org/10.1007/s00253-011-3185-7 DO - 10.1007/s00253-011-3185-7 ID - Brandenburg2011 ER - TY - STD TI - Martinez de Tejada G, Sánchez-Gómez S, Razquin-Olazaran I, et al.: Bacterial cell wall compounds as promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyamines.Curr Drug Targets, in press. ID - ref36 ER - TY - JOUR AU - Opal, S. M. AU - Palardy, J. E. AU - Marra, M. N. AU - Fisher, C. J. AU - McKelligon, B. M. AU - Scott, R. W. PY - 1994 DA - 1994// TI - Relative concentrations of endotoxin-binding proteins in body fluids during infection JO - Lancet VL - 344 UR - https://doi.org/10.1016/S0140-6736(94)91767-1 DO - 10.1016/S0140-6736(94)91767-1 ID - Opal1994 ER - TY - JOUR AU - Marra, M. N. AU - Wilde, C. G. AU - Griffith, J. E. AU - Snable, J. L. AU - Scott, R. W. PY - 1990 DA - 1990// TI - Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity JO - J Immunol VL - 144 ID - Marra1990 ER - TY - JOUR AU - Calvano, S. E. AU - Thompson, W. A. AU - Marra, M. N. PY - 1994 DA - 1994// TI - Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis JO - Arch Surg VL - 129 UR - https://doi.org/10.1001/archsurg.1994.01420260116016 DO - 10.1001/archsurg.1994.01420260116016 ID - Calvano1994 ER - TY - JOUR AU - Rintala, E. AU - Peuravuori, H. AU - Pulkki, K. AU - Voipio-Pulkki, L. M. AU - Nevalainen, T. PY - 2000 DA - 2000// TI - Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome JO - Intensive Care Med VL - 26 UR - https://doi.org/10.1007/s001340000616 DO - 10.1007/s001340000616 ID - Rintala2000 ER - TY - JOUR AU - Levin, M. AU - Quint, P. A. AU - Goldstein, B. PY - 2000 DA - 2000// TI - Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group JO - Lancet VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)02712-4 DO - 10.1016/S0140-6736(00)02712-4 ID - Levin2000 ER - TY - JOUR AU - Duits, L. A. AU - Rademaker, M. AU - Ravensbergen, B. PY - 2001 DA - 2001// TI - Inhibition of hBD-3, but not hBD-1 and hBD-2, mRNA expression by corticosteroids JO - Biochem Biophys Res Commun VL - 280 UR - https://doi.org/10.1006/bbrc.2000.4157 DO - 10.1006/bbrc.2000.4157 ID - Duits2001 ER - TY - JOUR AU - Book, M. AU - Chen, Q. AU - Lehmann, L. E. PY - 2007 DA - 2007// TI - Inducibility of the endogenous antibiotic peptide beta-defensin 2 is impaired in patients with severe sepsis JO - Crit Care VL - 11 UR - https://doi.org/10.1186/cc5694 DO - 10.1186/cc5694 ID - Book2007 ER - TY - JOUR AU - Thomas, N. J. AU - Carcillo, J. A. AU - Doughty, L. A. AU - Sasser, H. AU - Heine, R. P. PY - 2002 DA - 2002// TI - Plasma concentrations of defensins and lactoferrin in children with severe sepsis JO - Pediatr Infect Dis J VL - 21 UR - https://doi.org/10.1097/00006454-200201000-00008 DO - 10.1097/00006454-200201000-00008 ID - Thomas2002 ER - TY - JOUR AU - Berkestedt, I. AU - Herwald, H. AU - Ljunggren, L. AU - Nelson, A. AU - Bodelsson, M. PY - 2010 DA - 2010// TI - Elevated plasma levels of antimicrobial polypeptides in patients with severe sepsis JO - J Innate Immun VL - 2 UR - https://doi.org/10.1159/000317036 DO - 10.1159/000317036 ID - Berkestedt2010 ER - TY - JOUR AU - Li, J. AU - Nation, R. L. AU - Turnidge, J. D. PY - 2006 DA - 2006// TI - Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections JO - Lancet Infect Dis VL - 6 UR - https://doi.org/10.1016/S1473-3099(06)70580-1 DO - 10.1016/S1473-3099(06)70580-1 ID - Li2006 ER - TY - JOUR AU - Cruz, D. N. AU - Antonelli, M. AU - Fumagalli, R. PY - 2009 DA - 2009// TI - Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial JO - JAMA VL - 301 UR - https://doi.org/10.1001/jama.2009.856 DO - 10.1001/jama.2009.856 ID - Cruz2009 ER - TY - JOUR AU - Martin, E. L. AU - Cruz, D. N. AU - Monti, G. PY - 2010 DA - 2010// TI - Endotoxin removal: how far from the evidence? The EUPHAS 2 Project JO - Contrib Nephrol VL - 167 UR - https://doi.org/10.1159/000315926 DO - 10.1159/000315926 ID - Martin2010 ER - TY - JOUR AU - Pini, A. AU - Falciani, C. AU - Mantengoli, E. PY - 2010 DA - 2010// TI - A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo JO - FASEB J VL - 24 UR - https://doi.org/10.1096/fj.09-145474 DO - 10.1096/fj.09-145474 ID - Pini2010 ER - TY - JOUR AU - Wu, G. AU - Fan, X. AU - Li, L. PY - 2010 DA - 2010// TI - Interaction of antimicrobial peptide s-thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli JO - Int J Antimicrob Agents VL - 35 UR - https://doi.org/10.1016/j.ijantimicag.2009.11.009 DO - 10.1016/j.ijantimicag.2009.11.009 ID - Wu2010 ER -